← Leaderboards
Kathryn Margaret Edwards
Vanderbilt University
$34,281,287
Attributed
$34,281,287
Total exposure
31
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.9M · FY2005–21$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$27,113,662 · 28
CDC$7,167,625 · 3
By mechanism
N01$25,307,714 · 3
U18$3,605,606 · 2
U01$3,562,019 · 1
M01$1,682,784 · 24
T32$123,164 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Helen Keipp Talbot$7,247,906
- Katherine A Poehling$3,966,679
- Sarika U Peters$2,112,916
- Peter F Wright$12,188,551
- Barney S Graham$269,836
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesVaccinesEvaluationConduct Clinical TrialsContractsDesignInfectious Disease TreatmentRouteInvestigationNamed GroupClinical TrialsVaccine CandidateSourceUnited States National Institutes Of HealthInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseFundingGrantResearch PersonnelClinical ResearchHuman SubjectInfluenza Virus VaccineChildhoodInfluenza A Virus, H5n1 Subtype
Grant awards (78)
Vaccine and Treatment Evaluation Unit: Pertussis Vaccine Development$14,174
N01 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Pertussis Vaccine Development$333,763
N01 · FY2017 · AI · contact PI
VTEU: Phase I Influenza Vaccine Clinical Trial$4,825,191
N01 · FY2016 · AI · contact PI
VTEU: Systems Biology Based Assessment of a Pertussis Vaccine$4,055,311
N01 · FY2016 · AI · contact PI
Respiratory Syncytial Virus: Diagnostics Development - VTEU$1,570,670
N01 · FY2015 · AI · contact PI
Vaccine and Treatment Evaluation Units$251,317
N01 · FY2015 · AI · contact PI
Phase I Study of Pandemic Flu Vaccines - VTEU$112,065
N01 · FY2015 · AI · contact PI
Systems Biology Based Assessment of a Pertussis Vaccine - VTEU$66,165
N01 · FY2015 · AI · contact PI
Vaccine and Treatment Evaluation Units$335,005
N01 · FY2014 · AI · contact PI
Vaccine and Treatment Evaluation Units$300,000
N01 · FY2014 · AI · contact PI
Vaccine and Treatment Evaluation Units$96,242
N01 · FY2014 · AI · contact PI
Respiratory Syncytial Virus: Diagnostic and Vaccine Assays - VTEU$57,339
N01 · FY2014 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$1,721,918
N01 · FY2013 · AI · contact PI
Vaccine and Treatment Evaluation Units$650,000
N01 · FY2013 · AI · contact PI
Vaccine and Treatment Evaluation Units$600,000
N01 · FY2013 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$600,000
N01 · FY2013 · AI · contact PI
Vaccine and Treatment Evaluation Units$550,000
N01 · FY2013 · AI · contact PI
Vaccine and Treatment Evaluation Units$500,000
N01 · FY2013 · AI · contact PI
Vaccine and Treatment Evaluation Units$300,000
N01 · FY2013 · AI · contact PI
The Incidence and Etiology of Influenza-Associated Community-Acquired Pneumonia i$16,025
U18 · FY2013 · IP · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$500,000
N01 · FY2012 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$500,000
N01 · FY2012 · AI · contact PI
Vaccine and Treatment Evaluation Units$300,000
N01 · FY2012 · AI · contact PI
The Incidence and Etiology of Influenza-Associated Community-Acquired Pneumonia i$100,000
U18 · FY2012 · IP · contact PI
Vaccine and Treatment Evaluation Units$50,000
N01 · FY2012 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$1,500,000
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$1,200,000
N01 · FY2011 · AI · contact PI
The Incidence and Etiology of Influenza-Associated Community-Acquired Pneumonia i$1,093,996
U18 · FY2011 · IP · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$1,018,554
N01 · FY2011 · AI · contact PI
Vaccine and Treatment Evaluation Units$500,000
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$500,000
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$500,000
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$500,000
N01 · FY2011 · AI · contact PI
Vaccine and Treatment Evaluation Units$300,000
N01 · FY2011 · AI · contact PI
The Incidence and Etiology of Influenza-Associated Pneumonia in Hospitalized Pers$995,767
U18 · FY2010 · IP · contact PI
Enhanced Surveillance: New Vaccine Preventable Diseases$497,561
U01 · FY2010 · IP · contact PI
The Incidence and Etiology of Influenza-Associated Pneumonia in Hospitalized Pers$399,818
U18 · FY2010 · IP · contact PI
The Incidence and Etiology of Influenza-Associated Pneumonia in Hospitalized Pers$1,000,000
U18 · FY2009 · IP · contact PI
Vaccine and Treatment Evaluation Units$1,000,000
N01 · FY2009 · AI · contact PI
Enhanced Surveillance: New Vaccine Preventable Diseases$604,248
U01 · FY2009 · IP · contact PI
Enhanced Surveillance: New Vaccine Preventable Diseases$914,792
U01 · FY2008 · IP · contact PI
INF 2205-H5 CHIRON (DMID PROTOCOL 04-062)$12,018
M01 · FY2008 · RR · contact PI
INF 0404-H5 (DMID PROTOCOL 04-076)$5,880
M01 · FY2008 · RR · contact PI
CSL - INF 0506$5,740
M01 · FY2008 · RR · contact PI
CMV FEMALE (DMID 04-039) / CMV MALE (DMID 05-0126)$1,944
M01 · FY2008 · RR · contact PI
BAXTER H5$1,347
M01 · FY2008 · RR · contact PI
INFANT FLU VACCINE STUDY$246
M01 · FY2008 · RR · contact PI
Enhanced Surveillance: New Vaccine Preventable Diseases$785,743
U01 · FY2007 · IP · contact PI
INF 2205-H5 CHIRON (DMID PROTOCOL 04-062)$255,103
M01 · FY2007 · RR · contact PI
INF 0404-H5 (DMID PROTOCOL 04-076)$124,817
M01 · FY2007 · RR · contact PI
NICHD Institutional Training for Pediatricians$123,164
T32 · FY2007 · HD · contact PI
CSL - INF 0506$121,832
M01 · FY2007 · RR · contact PI
CMV FEMALE (DMID 04-039) / CMV MALE (DMID 05-0126)$41,274
M01 · FY2007 · RR · contact PI
BAXTER H5$28,594
M01 · FY2007 · RR · contact PI
INFANT FLU VACCINE STUDY$5,220
M01 · FY2007 · RR · contact PI
Enhanced Surveillance: New Vaccine Preventable Diseases$759,675
U01 · FY2006 · IP · contact PI
INF 1505 - ID/IM (DMID PROTOCOL 050075)$67,536
M01 · FY2006 · RR · contact PI
INF 0404-H5 (DMID PROTOCOL 04-076)$43,626
M01 · FY2006 · RR · contact PI
DMID STX1 STUDY$33,559
M01 · FY2006 · RR · contact PI
ANTHRAX VACCINE STUDY$15,941
M01 · FY2006 · RR · contact PI
INFANT FLU VACCINE STUDY$1,677
M01 · FY2006 · RR · contact PI
EVALUATION OF CONTROL MEASURES AGAINST DISEASES OTHER THAN AIDS-266025-266025462$0
N01 · FY2006 · AI · contact PI
ANTHRAX VACCINE STUDY$245,467
M01 · FY2005 · RR
RESPONSES TO NASAL SPRAY AND SHOT FLU VACCINES$65,857
M01 · FY2005 · RR
A MULTICENTER, DOUBLE-BLIND, RANDOMIZED STUDY OF THE SAFETY AND EFFICACY OF$36,382
M01 · FY2005 · RR
CELLULAR IMMUNE RESPONSES IN CHILDREN WITH CONFIRMED INFLUENZA A INFECTION$460
M01 · FY2005 · RR
EXTENSIVE SWELLING REACTIONS AFTER BOOSTER DOSES OF ACELLULAR PERTUSSIS$460
M01 · FY2005 · RR
Enhanced Surveillance: New Vaccine Preventable Diseases$0
U01 · FY2005 · IP
Evaluation of New Bacterial and Viral Candidate Vaccine$413,748
M01 · FY2004 · RR
A Multicenter, Double-Blind, Randomized Study of the Safety and Efficacy of...$128,196
M01 · FY2004 · RR
Responses to Nasal Spray and Shot Flu Vaccines$24,759
M01 · FY2004 · RR
EXTENSIVE SWELLING REACTIONS AFTER BOOSTER DOSES OF ACELLULAR PERTUSSIS$1,101
M01 · FY2004 · RR
Enhanced Surveillance: New Vaccine Preventable Diseases$0
U01 · FY2004 · IP
PLECONARIL (VP63843) THERAPY--INFANTS W/ ENTEROVIRAL MEN$0
M01 · FY2002 · RR
PLECONARIL (VP63843) THERAPY--INFANTS W/ ENTEROVIRAL MEN$0
M01 · FY2001 · RR
PLECONARIL (VP63843) THERAPY--INFANTS W/ ENTEROVIRAL MEN$0
M01 · FY2001 · RR
PLECONARIL (VP63843) THERAPY--INFANTS W/ ENTEROVIRAL MEN$0
M01 · FY2001 · RR
PLECONARIL (VP63843) THERAPY--INFANTS W/ ENTEROVIRAL MEN$0
M01 · FY2000 · RR